Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed250%
terminated125%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension

NCT05056532
terminatednot_applicable

Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator

NCT02185521
unknown

Nigrosomal Iron Imaging in Parkinson's Disease

NCT03022357
completed

An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia

NCT01309373

Clinical Trials (4)

Showing 4 of 4 trials
NCT05056532

Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension

Completed
NCT02185521Not Applicable

Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator

Terminated
NCT03022357

Nigrosomal Iron Imaging in Parkinson's Disease

Unknown
NCT01309373

An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4